Small Lymphocytic Lymphoma
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 clinical trial update describes modified CD19/CD20 CAR-T cells for recurrent or refractory B-cell lymphoma or chronic lymphocytic …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This [Phase 2]
Phase 2 trial evaluating LP-168 in combination with obinutuzumab for chronic lymphocytic leukemia/small lymphocytic lymphoma and related var…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL [NA]
This clinical trial update describes a study evaluating the combination of anti-CD19 CAR-T therapy with a BTK inhibitor to treat newly diagn…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]
Phase 1 imaging trial evaluating 64Cu-LLP2A in hematologic malignancies is currently recruiting, targeting multiple myeloma and various lymp…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia [Phase 1]
This clinical trial update announces a Phase 1 study of CAP-100 for relapsed/refractory chronic lymphocytic leukemia and small lymphocytic l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL [Phase 1]
Phase 1 clinical trial evaluating autologous CD19-specific CAR T cells (TBI-2001) for relapsed or refractory CD19+ B-cell lymphoma, chronic …
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Allo HSCT Using RIC and PTCy for Hematological Diseases [Phase 2]
Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and post-transplan…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]
Mayo Clinic is conducting a Phase 1 clinical trial evaluating a CD19-directed CAR-T cell therapy for relapsed/refractory B-cell malignancies…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Combating Cancer-Related Fatigue: A Personalized Supportive Care Program [NA]
This clinical trial update reports a UNC Lineberger Comprehensive Cancer Center study recruiting participants for a personalized supportive …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL [Phase 1]
This clinical trial update describes a Phase 1 study of APG-2575, studied as a single agent or in combination with other therapies for chron…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Ongoing Italian study by GIMEMA recruiting to improve diagnosis and management of chronic lymphocytic leukemia and related conditions (inclu…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is activ…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
This clinical trial update announces a study of lisocabtagene maraleucel for relapsed/refractory Chronic Lymphocytic Leukemia and Small Lymp…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. [Phase 1, Phase 2]
A Phase 1/2 open-label trial evaluating the safety and efficacy of concomitant administration of anti-CD19 CAR T-cell therapy and Lenalidomi…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating zanubrutinib in combination with obinutuzumab in untreated chronic lymphocytic leukemia or small lymphoc…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: A Study of FCN-338 in Patients With Chronic CLL/SLL [Phase 1]
FCN-338 is being evaluated in a Phase 1 trial for chronic lymphocytic leukemia and small lymphocytic lymphoma, with the study currently acti…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [Phase 1]
Phase 1 trial evaluating a triple combination of zanubrutinib, obinutuzumab, and lenalidomide in newly diagnosed chronic lymphocytic leukemi…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Current Status of BTKi Treatment for CLL/SLL in China
An update on a Bruton tyrosine kinase inhibitor (BTKi) trial for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in China,…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL [Phase 1, Phase 2]
A Phase 1/2 study evaluating MS-553 for chronic lymphocytic leukemia and small lymphocytic lymphoma was terminated.
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy [Phase 2]
This update outlines a Phase 2 clinical trial comparing a fixed-cycle regimen including orelabrutinib with BTK inhibitor monotherapy for chr…
-
CLINICAL_TRIALS research · 2022-12-01Clinical Trial Update: Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating pyrimethamine for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma; re…
-
CLINICAL_TRIALS research · 2019-02-01Clinical Trial Update: A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL [Phase 1]
Phase I trial evaluating AC0010 in patients with CLL/SLL, mantle cell lymphoma, diffuse large B-cell lymphoma, and other non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2014-06-05Clinical Trial Update: Observational Study of Low Dose FCR in Elderly/Comorbid CLL/SLL: The Q-lite Project
Observational study (the Q-lite Project) evaluating low-dose fludarabine-cyclophosphamide-rituximab (FCR) in elderly or comorbid patients wi…
-
CLINICAL_TRIALS research · 2007-04-17Clinical Trial Update: Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease [Phase 1]
Phase 1 safety study evaluating CAT-8015 immunotoxin in patients with chronic lymphocytic leukemia, prolymphocytic leukemia, or small lympho…